Weidong Xu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Transforming Growth Factor

Top Venues

Cancer gene therapy

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Weidong Xu, Soon Cheon Shin, Renee Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy Mangold, Bellur S Prabhakar, Hans Schreiber
The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFβ Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model. Research square (2023)